WaveMan
WaveMan · Company
WOK · Work Medical Technology Group Ltd
> Search tickers & screens ⌘K
LIVE
← All companies

WOK WORK Medical Technology (WOK) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001929783
Quote by TradingView
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about WOK

Insiders, 180 days
-$178.4K net sold
1 buyer · 1 seller · 0% of sales under a 10b5-1 plan

WORK Medical Technology insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, WORK Medical Technology Group LTD insiders sold a net $178.4K of stock across 15 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
HRT FINANCIAL LP
SELL
2026-06-23 SECtraded 2026-06-18
136,665
$528.9K
-52.4%
Context
  • 14 earlier Form 4 trades (code P or S) here by this insider (10 buys, 4 sales), the last on Jun 17, 2026.
  • -77.9% median (-75.9% mean) 90-day return after 10 previous buys.
  • The trade is 110.3% of the 123,944 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider HRT FINANCIAL LP sold about $528.9K of WOK on Jun 18, 2026, the largest insider sale at the company on our record.
HRT FINANCIAL LP
BUY
2026-06-23 SECtraded 2026-06-17
880,456
$44.0K
-52.4%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (9 buys, 4 sales), the last on Jun 16, 2026.
  • -78.0% median (-77.9% mean) 90-day return after 9 previous buys.
  • The trade is 69.2% of the 1,271,912 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Insider HRT FINANCIAL LP bought about $44.0K of WOK on Jun 17, 2026.
HRT FINANCIAL LP
SELL
2026-06-17 SECtraded 2026-06-16
2,904,567
$174.3K
-63.4%
Context
  • 12 earlier Form 4 trades (code P or S) here by this insider (9 buys, 3 sales), the last on Jun 15, 2026.
  • -78.0% median (-77.9% mean) 90-day return after 9 previous buys.
  • The trade is 742.0% of the 391,456 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider HRT FINANCIAL LP sold about $174.3K of WOK on Jun 16, 2026.
HRT FINANCIAL LP
BUY
2026-06-17 SECtraded 2026-06-15
268,927
$26.9K
-63.4%
Context
  • 11 earlier Form 4 trades (code P or S) here by this insider (8 buys, 3 sales), the last on Jun 12, 2026.
  • -78.6% median (-78.0% mean) 90-day return after 8 previous buys.
  • The trade is 8.2% of the 3,296,023 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Insider HRT FINANCIAL LP bought about $26.9K of WOK on Jun 15, 2026.
HRT FINANCIAL LP
BUY
2026-06-16 SECtraded 2026-06-12
48,108
$3.8K
-72.8%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (7 buys, 3 sales), the last on Jun 11, 2026.
  • -79.1% median (-78.5% mean) 90-day return after 7 previous buys.
  • The trade is 1.6% of the 3,027,096 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Insider HRT FINANCIAL LP bought about $3.8K of WOK on Jun 12, 2026.
15 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 10 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$178.4K over 180 days
-$178.4K of it by a 10%+ holder
below 51% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-14.4% year over year
below 89% of Medical Devices
Margin
-10.9% net margin
more than 55% of Medical Devices
Buybacks
no share repurchases reported
Short interest
1.0% of shares outstanding short · 2.8 days to cover · settled 2026-10-15
below 72% of Medical Devices
What changed in the last 30 days
Oct 28Insider selling stopped: no sales in 90 days after 5 in the prior 90
Why it matters
The absence is the signal: 5 sales in one 90-day window and none in the next is a change of behaviour, not a filing.
Oct 28Insider buying stopped: no purchases in 90 days after 10 in the prior 90
Why it matters
The absence is the signal: 10 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.

Watch WOK

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-100.0%12M
-100%-45%+10%+64%2025-102025-122026-022026-042026-062026-082026-10 2026-06-18 · HRT FINANCIAL LP sold $528.9K2026-06-01 · HRT FINANCIAL LP bought $384.5K2026-06-09 · HRT FINANCIAL LP sold $380.9K2026-05-29 · HRT FINANCIAL LP sold $262.0K2026-06-08 · HRT FINANCIAL LP bought $248.7K2026-06-02 · HRT FINANCIAL LP sold $193.4K2026-06-11 · HRT FINANCIAL LP bought $182.6K2026-06-10 · HRT FINANCIAL LP bought $176.5K2026-06-16 · HRT FINANCIAL LP sold $174.3K2026-06-04 · HRT FINANCIAL LP bought $150.7K2026-05-28 · HRT FINANCIAL LP bought $138.2K2026-06-17 · HRT FINANCIAL LP bought $44.0K2026-06-15 · HRT FINANCIAL LP bought $26.9K2026-06-05 · HRT FINANCIAL LP bought $4.9K2026-06-12 · HRT FINANCIAL LP bought $3.8K
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns WOK: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in WOK

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

WOK planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $178.4K sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

WOK financials

Revenue growth
-14.4%
XBRL, annual
Net margin
-10.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Debt to equity
0.35x
current debt only, 2025-09-30; equity 2025-09-30
Cash flow to debt
n/a
needs four quarters of operating cash flow
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
$19.4M
market value at close 2026-10-27 on 2024-09-30 shares, plus current debt only, 2025-09-30, minus cash 2025-09-30
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-092024-092023-092022-09
Revenue$9.8M$11.5M$13.6M$19.7M
Gross profit$2.3M$2.9M$4.1M$4.4M
Net income-$1.1M-$3.5M$112.0K$865.2K
EPS (diluted)-0.04-0.270.010.07
Operating cash flow$6.2M-$2.2M$2.2M-$2.3M
Cash$4.1M$6.6M$1.6M$731.2K
SEC XBRL, fiscal years, as known on 2026-10-28

WOK Stock Sonar score 4/7 axes

Find similar shapesCompare

WOK ranks highest on risk and compliance (78th percentile) and insider conviction (50th), and lowest on growth (11th), among Medical Devices peers.

Financial health
46
Inputs
  • Debt to equity0.35x · 46 pct, sector of 159
  • Cash flow to debtneeds four quarters of operating cash flow
Growth
11
Inputs
  • Revenue growth, YoY-14.4% · 11 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
50
Inputs
  • Net Form 4 buying (codes P and S), 180d-$178K · 47 pct, sector of 140
  • Insider buyers, 180d1 · 52 pct, sector of 142
Risk and compliance
78
Inputs
  • Short interest, % of shares outstanding (no float on file)+1.0% · 78 pct, sector of 241
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Profitability, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

WOK filings, in plain words

Are WORK Medical Technology insiders buying or selling WOK?

In the 180 days to 2026-10-28, WORK Medical Technology insiders were net sellers, a net $178.4K: $1.4M of purchases and $1.5M of sales reported on Form 4, by 1 buyer and 1 seller.

Read the full summary

In the 180 days to 2026-10-28, WORK Medical Technology insiders were net sellers of WOK, a net $178.4K across purchases and sales reported on Form 4 by 1 buyer and 1 seller. Most of that figure, $178.4K, came from a holder of 10% or more rather than an officer or director. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies